FLGT vs. CPRX
Compare and contrast key facts about Fulgent Genetics, Inc. (FLGT) and Catalyst Pharmaceuticals, Inc. (CPRX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: FLGT or CPRX.
Key characteristics
| FLGT | CPRX | |
|---|---|---|
| YTD Return | -26.53% | -10.65% |
| 1Y Return | -27.58% | -9.52% |
| 3Y Return (Ann) | -34.79% | 45.63% |
| 5Y Return (Ann) | 25.82% | 19.94% |
| Sharpe Ratio | -0.64 | -0.20 |
| Daily Std Dev | 42.16% | 48.05% |
| Max Drawdown | -89.11% | -94.25% |
| Current Drawdown | -88.45% | -28.65% |
Fundamentals
| FLGT | CPRX | |
|---|---|---|
| Market Cap | $601.00M | $1.76B |
| EPS | -$5.63 | $0.63 |
| PE Ratio | 9.30 | 23.63 |
| PEG Ratio | 1.32 | 0.00 |
| Revenue (TTM) | $289.21M | $398.20M |
| Gross Profit (TTM) | $366.90M | $160.02M |
| EBITDA (TTM) | -$46.55M | $119.69M |
Correlation
The correlation between FLGT and CPRX is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
FLGT vs. CPRX - Performance Comparison
In the year-to-date period, FLGT achieves a -26.53% return, which is significantly lower than CPRX's -10.65% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
FLGT vs. CPRX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Fulgent Genetics, Inc. (FLGT) and Catalyst Pharmaceuticals, Inc. (CPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
FLGT vs. CPRX - Dividend Comparison
Neither FLGT nor CPRX has paid dividends to shareholders.
Drawdowns
FLGT vs. CPRX - Drawdown Comparison
The maximum FLGT drawdown since its inception was -89.11%, smaller than the maximum CPRX drawdown of -94.25%. Use the drawdown chart below to compare losses from any high point for FLGT and CPRX. For additional features, visit the drawdowns tool.
Volatility
FLGT vs. CPRX - Volatility Comparison
The current volatility for Fulgent Genetics, Inc. (FLGT) is 8.10%, while Catalyst Pharmaceuticals, Inc. (CPRX) has a volatility of 9.81%. This indicates that FLGT experiences smaller price fluctuations and is considered to be less risky than CPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
FLGT vs. CPRX - Financials Comparison
This section allows you to compare key financial metrics between Fulgent Genetics, Inc. and Catalyst Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities